Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Sychev

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Kardiologiia|May 13, 2010
[Which of algorithms of warfarin dosing based on results of pharmacogenetic testing is suitable for patients in Russia]D A Sychev, I M Antonov, E S Kropacheva, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|October 10, 2015
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions]V I Sokolova, D A Sychev, M B Babarina, et al.
Pharmacogenomics and Personalized Medicine|June 26, 2015
The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitorsD A Sychev, N P Denisenko, Z M Sizova, et al.
Kardiologiia|December 26, 2017
[Clinico-Pharmacological and Clinical Basis of Multiplicity of Intake of Novel Oral Anticoagulants]D A Sychev, A N Levanov, I V Tsomaya, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 23, 2018
[Is it personalized treatment of dementia based on the CYP2D6 gene polymorphism possible?]A D Chebotareva, O S Levin, D D Markov, et al.
Advances in Gerontology = Uspekhi Gerontologii|December 6, 2020
[Drug therapy of atrial fibrillation in elderly patients.]E P Popova, O T Bogova, S N Puzin, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|July 24, 2014
[Treatment approaches for bronchopulmonary infection in myasthenia gravis patients]V I Sokolova, A G Sanadze, D A Sychev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 12, 2019
[Genetic and non-genetic factors of laboratory resistance to clopidogrel in patients with ischemic stroke]D A Sychev, V V Shprakh, E Yu Kitaeva, et al.
Terapevticheskii Arkhiv|October 14, 2016
[Optimizing the prophylaxis of hospital-acquired deep vein thrombosis and pulmonary thromboembolism]G I Nazarenko, E B Kleymenova, S A Payushchik, et al.
Pharmacogenomics|January 20, 2025
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective studyA A Skryabina, V V Nikiforov, M Z Shakhmardanov, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Kardiologiia|May 13, 2010
[Which of algorithms of warfarin dosing based on results of pharmacogenetic testing is suitable for patients in Russia]D A Sychev, I M Antonov, E S Kropacheva, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|October 10, 2015
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions]V I Sokolova, D A Sychev, M B Babarina, et al.
Pharmacogenomics and Personalized Medicine|June 26, 2015
The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitorsD A Sychev, N P Denisenko, Z M Sizova, et al.
Kardiologiia|December 26, 2017
[Clinico-Pharmacological and Clinical Basis of Multiplicity of Intake of Novel Oral Anticoagulants]D A Sychev, A N Levanov, I V Tsomaya, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 23, 2018
[Is it personalized treatment of dementia based on the CYP2D6 gene polymorphism possible?]A D Chebotareva, O S Levin, D D Markov, et al.
Advances in Gerontology = Uspekhi Gerontologii|December 6, 2020
[Drug therapy of atrial fibrillation in elderly patients.]E P Popova, O T Bogova, S N Puzin, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|July 24, 2014
[Treatment approaches for bronchopulmonary infection in myasthenia gravis patients]V I Sokolova, A G Sanadze, D A Sychev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 12, 2019
[Genetic and non-genetic factors of laboratory resistance to clopidogrel in patients with ischemic stroke]D A Sychev, V V Shprakh, E Yu Kitaeva, et al.
Terapevticheskii Arkhiv|October 14, 2016
[Optimizing the prophylaxis of hospital-acquired deep vein thrombosis and pulmonary thromboembolism]G I Nazarenko, E B Kleymenova, S A Payushchik, et al.
Pharmacogenomics|January 20, 2025
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective studyA A Skryabina, V V Nikiforov, M Z Shakhmardanov, et al.
Pageof 9